Tilposide Lyophilized powder Factory wholesale

Introduction to Tilposide

Tilposide is a cutting-edge glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) dual-receptor agonist designed for weekly administration. This innovative research peptide has shown significant benefits in weight management and blood sugar regulation, making it a promising candidate for obesity and diabetes treatment.

How Does Tilposide Work?

Tilposide works through a dual mechanism of action, combining the effects of GLP-1 and GIP receptors:

✔ GLP-1 Receptor Activation

• Stimulates insulin secretion to lower blood sugar levels
• Delays gastric emptying, reducing hunger and promoting weight loss
• Suppresses appetite, helping with long-term weight management

✔ GIP Receptor Activation

• Enhances insulin secretion for better glucose control
• Inhibits gastric acid and pepsin secretion, improving digestion
• Supports metabolic health, complementing GLP-1’s effects

Key Benefits of Tilposide

✅ Effective Weight Loss Solution – Reduces appetite and promotes fat metabolism
✅ Diabetes Management – Improves blood sugar levels and insulin sensitivity
✅ Weekly Dosing – Convenient and long-lasting effects
✅ High Purity & Fully Synthetic – Reliable and consistent quality
✅ Clinical Potential – Supports obesity and metabolic disorder research

Product Specifications

Storage Conditions

🔹 Store in a cool, dry place away from light
🔹 Recommended storage: -15°C or lower for long-term stability

Wholesale & Customization Options

We offer bulk supply of Tilposide lyophilized powder in 10mg, 15mg, and 20mg vials for research purposes.
✔ High-purity research-grade peptide
✔ Fast global shipping with secure packaging
✔ Custom formulations and packaging available

Order Tilposide Today!

Looking for a trusted supplier of Tilposide research peptides? Contact us now for wholesale pricing and bulk orders!

📩 Get a Free Quote Now! 🚀

Product Advantages:

• Production Form: Fully synthetic, leading to a significant reduction in body weight. It also demonstrates strong GLP-1 receptor agonist activity and GIP receptor agonist activity, offering potential for effective metabolic control.

• Capacity: Manufactured in a 500L reactor, with an impressive annual output of 40kg, ensuring reliable and large-scale production.

• Technical Support: We offer comprehensive stability research and DMF (Drug Master File) application support to facilitate smooth regulatory submission processes.

Related Products:

• Telposide Side Chains
• Smegglutide
• Liraglutide